|
|
|
Ibio Inc 
|
2.01 -0.01 (-0%) |
02-24 16:00 |
Open: |
2.08 |
Pre close: |
2.02 |
Target:
|
2.67
|
High: |
2.08 |
Low: |
2 |
Resistance:
|
2.29
2.83
|
Volume: |
5,095,274 |
Market Cap: |
434M |
Support:
|
1.41
1.17
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
2.02
 |
MACD |
MACD(12,26):
|
0.12  |
MA(20): |
2.11  |
Signal(12,26,9): |
0.18  |
MA(100): |
1.69  |
Stochastic Oscillator |
%K(14,3):
|
31.52  |
MA(250): |
1.89  |
%D(3): |
34.84  |
Average Volume(K) |
3-Month: |
1786960
|
52-Week |
High:
|
7.45 |
10-Days: |
1656515 |
Low: |
0.76 |
RSI |
RSI(14):
|
51.35  |
Change(%): |
131.0 |
Financials, Statistics and Valuation |
EPS |
-0.975 |
Return on Equity (ttm) |
-320.6 |
Shares Out. (M) |
174.42 |
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-24.0 |
Shares Float (M) |
117.05 |
EPS Est. Next Year |
-0.200 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.78 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-81.8 |
% Held by Institutions |
11.56 |
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.012 |
Shares Short (K) |
20000 |
Book Value (p.s.) |
0.040 |
EBITDA (p.s.) |
-0.074 |
P/E |
-2.06 |
Sales Per Share |
0.008 |
Qtrly Earnings Growth |
0.00 |
P/BV |
50.25 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.87 |
P/S |
267.62 |
Operating Margin |
-1138.46 |
Levered Free Cash Flow
(M) |
-7.82 |
P/CF |
-25.28 |
|
|
|
|
|